NEOGEN CORP NEOG

Latest FY: 2025 Healthcare Medical Devices
Market Price $11.64
Market Cap $2.59B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-3.2% YoY
$894.66M
3-Yr CAGR: 19.3%
Net Income ↓-11,491.6% YoY
-$1.09B
Net Margin: -122.1%
Free Cash Flow ↑45.7% YoY
-$41.28M
FCF Yield: -1.59%
EPS (Diluted) ↓-12,475.0% YoY
$-5.03
Basic: $-5.03
Return on Equity Efficiency
-52.7%
ROA: -2,049.3%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (NEOG)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $321.3M $153.1M $36.6M $0.97 $35.3M $21.1M
FY 2017 $361.6M +12.5% $172.0M $43.8M +19.8% $1.14 +17.5% $60.3M $45.7M +116.5%
FY 2018 $402.3M +11.2% $190.3M $63.1M +44.2% $1.21 +6.1% $69.1M $48.2M +5.4%
FY 2019 $414.2M +3.0% $191.9M $60.2M -4.7% $1.15 -5.0% $63.8M $49.2M +2.1%
FY 2020 $418.2M +1.0% $196.3M $59.5M -1.2% $1.13 -1.7% $85.9M $61.8M +25.7%
FY 2021 $468.5M +12.0% $215.1M $60.9M +2.4% $0.57 -49.6% $81.1M $54.4M -12.0%
FY 2022 $527.2M +12.5% $243.0M $48.3M -20.7% $0.45 -21.1% $68.0M $43.6M -19.8%
FY 2023 $822.4M +56.0% $406.0M $-22.9M -147.3% $-0.12 -126.7% $41.0M $-23.9M -154.8%
FY 2024 $924.2M +12.4% $463.9M $-9.4M +58.8% $-0.04 +66.7% $35.3M $-76.0M -218.2%
FY 2025 $894.7M -3.2% $421.4M $-1,092.0M -11,491.6% $-5.03 -12,475.0% $58.2M $-41.3M +45.7%
$

Valuation

Market Price $11.64
Market Cap $2.59B
Enterprise Value $3.35B
P/E Ratio N/A
P/B Ratio 1.22
FCF Yield -1.59%
Dividend Yield N/A
Shares Outstanding 217,673,000
%

Profitability & Margins

Gross Margin 47.10%
Operating Margin -118.59%
Net Margin -122.06%
Return on Equity (ROE) -52.72%
Return on Assets (ROA) -2,049.32%
Asset Turnover 16.79x
Revenue 3-Yr CAGR 19.28%
🛡️

Financial Health & Liquidity

Current Ratio 0.31
Cash Ratio 0.74
Debt / Equity 0.432
Debt / Assets 16.779
Cash & Equivalents $129.00M
Total Debt $894.11M
Book Value / Share $9.52
💧

Cash Flow Efficiency

Operating Cash Flow $58.24M
Capital Expenditures (CapEx) $99.52M
Free Cash Flow -$41.28M
OCF / Revenue 6.51%
FCF / Revenue -4.61%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-5.03
EPS (Basic) $-5.03
Dividends / Share N/A
Book Value / Share $9.52
EPS YoY Growth -12,475.00%
🏛️

Balance Sheet (FY 2025)

Total Assets $53.29M
Total Liabilities $174.01M
Stockholders' Equity $2.07B
Current Assets $53.29M
Current Liabilities $174.01M